"Finish Your Race" to help end acute myeloid leukemia

At age 49, Don Armstrong received a diagnosis of acute myeloid leukemia, an aggressive form of leukemia. Now at age 54, after five rounds of chemotherapy and a stem cell transplantation, he celebrates his "cancerversary" of being in remission for five years, with a pledge to help eradicate the disease.

Armstrong developed the Finish Your Race (www.finishyourrace.com) campaign and committed to run 10 races (five marathons and five half marathons) with Leukemia & Lymphoma Society's Team in Training program this year. He started in February and will finish up in December. His goal, in addition to running nearly 200 miles, is to raise half a million dollars for the LLS (you can check out his fundraising progress here). He also hopes to raise awareness of blood cancers and support patient services programs.

He began his marathon of marathons in his hometown of Fort Worth, Texas. A couple of weeks ago, he finished the marathon in Columbus, Ohio. Next stop is San Diego. The farthest he's traveled for a marathon this year is Paris, France.

To help him reach his goal of half a million dollars, Armstron is up for a $250,000 grant from the Pepsi Refresh Project. This is a similar grant contest that Drew Brees, Superbowl-winning quarterback of the New Orleans Saints, won for his city's ACS Hope Lodge ("Congratulations, Drew Brees").

If Armstrong is one of the top two vote getters by May 31, he'll be awarded half of his goal. "That's a big deal. All $250,000 will go through Finish Your Race to the Leukemia & Lymphoma Society," he says. "It's really exciting to me to be involved in funding a research project to help future patients, in terms of diagnosis and treatment, and hopefully eliminating the disease in the future."

I have a cousin who is training for the Team in Training marathon in San Diego. I've been receiving updates for the past year on her upcoming marathon and fundraising, sending her encouraging notes, and marveling at all she's accomplished. I'm so impressed by all she's done to prepare for this one marathon and the money she's raised for LLS. And she's running ONE. Armstrong is running 10. It certainly puts it into perspective for me.

I've also learned about all the hard work that goes into training for a single marathon--four to five months of structured training offered by Team in Training. Armstrong calls it "taking people from the couch to the finish line."

I'm sure Armstrong has inspired others to commit to their own marathon and fundraising goals for Team in Training--creating a true "pay it forward" effect, benefiting the LLS and blood cancer patients through increased awareness and funding. I'm even starting to feel the bug, from both my cousin and now Armstrong.

"You know," Armstrong says, "every day, the people I see inspire me to keep going with my running, so I guess it works both ways."

Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.
Special Feature
Share Your Art
Related Articles
BRCA Mutations May Cause Drug Resistance in Breast and Ovarian Cancer
There is a relationship between the genetics of BRCA1 and BRCA2 mutations and the risk of a patient with breast or ovarian cancer being resistant to platinum-based chemotherapy, according to recent research conducted at the Perelman School of Medicine at the University of Pennsylvania. The study’s senior author Katherine Nathanson, M.D., spoke with CURE about these findings.
Sarah Sciortino on Fertility and Sexuality in Younger Patients with Ovarian Cancer
Sarah Sciortino, MSW, LSW, Oncology Psychosocial Support Services Program Coordinator at University of Chicago Hospital, discusses the unique concerns that younger patients with ovarian cancer can face.
Caring With Confidence: Study Examines Caregiver Mastery and Patient Survival in GBM
A recent study found that the level of family caregiver mastery may have an effect on the survival of patients with glioblastoma.
Related Videos
Examining Quality of Life Issues for Patients With MPNs
Sandra Allen-Bard, MSN, ANCC, AOCNP, of Weill Cornell Medical Center, discusses the impact myeloproliferative neoplasms can have on patients' quality of life.
Elliott Winton on the Changing Landscape of MPN Treatment
Elliott Winton, M.D., researcher, physician and 2016 MPN Hero, discusses some of the drastic changes that happened over the past decade or so in the world of MPNs. 
Siddhartha Mukherjee on Increasing MPN Awareness
Siddhartha Mukherjee, M.D., Ph.D, an oncologist, researcher and Pulitzer Prize-winning science writer, discusses the increasing awareness about myeloproliferative neoplasms (MPNs).
//For side ad protocol